Greg Orlick

Market Development And Thought Leader Engagement AD (oncology, Sarcoma, Rare Disease) at SpringWorks Therapeutics

Greg Orlick has extensive work experience in the pharmaceutical industry. Greg is currently the Associate Market Development and Thought Leader Engagement Director at SpringWorks Therapeutics, where they lead the Thought Leader Liaison team and is responsible for building roles and responsibilities, mapping the KOL universe, and establishing educational strategies. Prior to this, Greg worked as the Associate Director Regional Marketing Oncology at Merck and as a Thought Leader Liaison Field Based Marketing Immunology, Allergy, and Respiratory at Regeneron Pharmaceuticals. Greg also worked at Takeda as a Thought Leader Liaison Gastroenterology, where they established the first-ever Thought Leader Liaison team. Before that, Greg was a Senior Thought Leader Liaison Oncology Breast Cancer and GBM at Genentech. Greg began their career at Genentech as a Hepatology/HIV Clinical Specialist and later worked as an Immunology Specialist Rheumatology and Gastroenterology at Centocor. Prior to their roles in the pharmaceutical industry, Greg was an Institutional Specialist/Key Account Manager at AstraZeneca. Throughout their career, Greg has demonstrated strong leadership skills and expertise in building relationships with key opinion leaders, speaker management, and sales.

Greg Orlick attended Western University where they earned a Bachelor of Arts degree in Public Administration from 1987 to 1991.

Links

Previous companies

Regeneron logo
Takeda Pharmaceutical logo
Genentech logo
Merck logo
AstraZeneca logo

Peers

View in org chart

Timeline

  • Market Development And Thought Leader Engagement AD (oncology, Sarcoma, Rare Disease)

    September, 2021 - present